Orion Biotech Opportunities Corp.

Status: Pre-Deal
U=S+W/5 W=S@11.50
IPO Proceeds, $M $200.0
IPO Date May 13, 2021
CEO James Huang
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology and life sciences

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings www.sec.gov
ORIA ORIAU ORIAW


Sign up for Free Trial

No credit card required

Sign in for more data on Orion Biotech Opportunities Corp.:

  • 7 directors & officers
  • 4 filings and events
  • 1 underwriters